临床儿科杂志 ›› 2014, Vol. 32 ›› Issue (12): 1176-.doi: 10.3969 j.issn.1000-3606.2014.12.020

• 实验研究 • 上一篇    下一篇

鼠神经生长因子对癫痫幼鼠脑保护作用的研究

臧欢欢1,2,陈琅1,刘蕊1,陈巧彬1,方琼1,林琳1   

  1. 1. 福建医科大学省立临床医学院 福建省立医院儿科( 福建福州 350001);2. 蚌埠医学院第一附属医院儿科( 安徽蚌埠 233300)
  • 收稿日期:2014-12-15 出版日期:2014-12-15 发布日期:2014-12-15
  • 通讯作者: 陈琅 E-mail:chenlang11@sohu.com
  • 基金资助:
    福建省医学创新基金项目(No.2009-CXB-8);福建省自然基金项目(No.2010J01121)

Protective effects of mouse nerve growth factor on brain in epileptic young rats

ZANG Huanhuan 1,2, CHEN Lang1, LIU Rui1, CHEN Qiaobin1, FANG Qiong1, LIN Lin1   

  1. 1.Provincial Clinic College of Fujian Medical University, Department of Pediatrics, Fujian Provincial Hospital, Fuzhou 350001, Fujian, China; 2.Department of Pediatrics, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233300, Anhui, China
  • Received:2014-12-15 Online:2014-12-15 Published:2014-12-15

摘要: 目的 探讨鼠神经生长因子(mNGF)对癫痫(EP)幼鼠海马金属硫蛋白Ⅰ/Ⅱ(MTⅠ/Ⅱ)和细胞色素C(Cyt C)表达的影响。方法 50只日龄19 d 的SD大鼠,随机分为对照组,EP组,mNGF低、中、高剂量组,每组10只。对照组每日予生理盐水注射;EP组腹腔注射戊四氮40 mg/(kg·d),连续21 d;mNGF低、中、高剂量组给予等剂量戊四氮21 d后,分别予mNGF 500 AU/(kg·d)、1 000 AU/(kg·d)、2 000 AU/(kg·d)肌肉注射,连续7 d。观察幼鼠体质量及行为学表现,免疫组织化学法检测海马MT Ⅰ/Ⅱ和Cyt C阳性细胞表达,实时荧光定量PCR法检测MT Ⅰ和Cyt C mRNA表达。结果 对照组、EP组以及mNGF低、中、高剂量组幼鼠海马的MT Ⅰ和Cyt C mRNA表达以及MTⅠ/Ⅱ和Cyt C阳性细胞数的差异有统计学意义(F=15.98~105.76,P均=0.000)。两两比较发现,EP组的MT Ⅰ和Cyt C mRNA表达明显升高,MTⅠ/Ⅱ和Cyt C阳性细胞数明显增多,均分别高于对照组和mNGF低、中、高剂量组,差异有统计学意义(P均<0.05);低剂量组的MT Ⅰ和Cyt C mRNA表达高于中、高剂量组,而MTⅠ/Ⅱ和Cyt C阳性细胞数高于高剂量组,差异有统计学意义(P均<0.05);中剂量与高剂量组间MT Ⅰ和Cyt C mRNA表达以及MTⅠ/Ⅱ和Cyt C阳性细胞数的差异无统计学意义(P均>0.05)。 结论 MT Ⅰ/Ⅱ作为一种应激性蛋白,与Cyt C共同参与了癫痫的过程。mNGF对癫痫后的海马有保护作用,且有剂量依赖。

Abstract:  Objective To explore the effects of mouse nerve growth factor (mNGF) on expression of metallothionein I/II (MT I/II) and cytochrome C (Cyt C) in hippocampus of pentylenetetrazol (PTZ)-induced epileptic (EP) young rats. Methods Fifty SD rats aged 19 days were randomly divided into control group, EP group, mNGF low, medium, and high dose groups. Each group had 10 rats. Control group was injected with normal saline every day, and EP group was intraperitoneally injected with PTZ 40 mg/(kg·d) for 21 days in succession. The mNGF low, medium, and high dose groups were respectively intramuscularly injected with mNGF 500, 1 000, 2 000 AU/(kg·d) for 7 days in succession after PTZ injection. Changes of body weight, behavioral performance were recorded. The positive cells of MT I/II, Cyt C were examined by immunohistochemisty. The levels of MT I, Cyt C mRNA in hippocampus were measured by real-time PCR. Results The number of MT I/II, Cyt C positive cells and the levels of MT I, Cyt C mRNA in hippocampus had significant differences among groups (F=15.98-105.76, P =0.000). The number of MT I/II, Cyt C positive cells and the levels of MT I, Cyt C mRNA of EP group were higher than those in control group, mNGF low, medium, and high dose groups (P<0.05). The number of MT I/II, Cyt C positive cells of mNGF low group were higher than those in mNGF high dose group (P<0.05). The levels of MT I, Cyt C mRNA of mNGF low group were higher than those in mNGF medium and high dose groups (P<0.05). The number of MT I/II, Cyt C positive cells and the levels of MT I, Cyt C mRNA had no differences between mNGF medium and high dose groups (P>0.05). Conclusions As a stress protein, metallothionein is involved in the process of chronic epilepsy along with Cyt C. mNGF has neuroprotective effects on the hippocampus of epileptic rats in dose dependent manner.